Amsali, Ziyan .
HRN: 28-13-67 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/20/2025
CEFTAZIDIME 1GM (VIAL)
11/20/2025
11/26/2025
IV
500mg
Q8
PCAP
Checking Initial Appropriateness
11/20/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
11/20/2025
12/06/2025
IVT
1.25gm
Q8
Pneumonia
Checking Initial Appropriateness